Interviews
View More
ASHP Midyear: Expert Discusses GLP-1 Medications and Incretin Mimetics for Diabetes Care

Jennifer Clements, a clinical professor and the director of pharmacy education at the University of South Carolina, discusses the pharmacists role in diabetes care.

California Wildfires Disrupt Medical Services, Community Rallies to Provide Support

The California wildfires caused many medical and community challenges, including triaging services, addressing basic needs, and supporting displaced residents.

Pharmacies Struggle Amid California Wildfires, Continue to Provide Much Needed Medication to Patients

Pharmacies are actively working to address issues and support their patients by collaborative with regulatory bodies like the Board of Pharmacy, and their engagement with the local community.

ASHP Midyear: Expert Discusses the GLP-1 Landscape for Diabetes Care

Pharmacy Times interviews Jennifer Clements, a clinical professor and the director of pharmacy education at the University of South Carolina, about glucagon-like peptide-1 receptors for diabetes treatment.

ASHP Midyear: New Therapies Are on the Horizon for Steatotic Liver Disease, but Access Challenges Remain

New medications like glucagon-like peptide-1 agonists and resmetirom show promise in reversing fatty liver disease and preventing progression.

ASHP Midyear: Pharmacists Play Key Role in Managing Chronic Kidney Disease With Emerging Therapies

Pharmacists can educate patients on controlling risk factors and stay up-to-date on emerging therapies like SGLT2 inhibitors and finerenone that can slow disease progression.

ASHP Midyear: Elevated Lp(a) Levels Pose Significant Cardiovascular Risk, Experts Emphasize Need for Awareness

Lp(a) is a critical risk factor for atherosclerotic cardiovascular disease, but current lipid-lowering therapies are largely ineffective at lowering Lp(a) levels.

ASHP Midyear: Bolus Dose of Antibiotic May Improve in Septic Shock

Administering first-dose antibiotics to septic shock patients via IV push rather than continuous infusion could improve the speed of antibiotic delivery and reduce logistical challenges.

ASH 2024: Zanubrutinib Monotherapy, With Obinutuzimab Demonstrates Durable Efficacy and Safety in CLL/SLL

Constantine Tam, MD, discusses zanubrutinib's efficacy in CLL/SLL, emphasizing its durability, high response rates, safety considerations, and evolving therapeutic potential in combination with other agents.

Official Media Partner

Official Media Partner

Official CE Partner

Official CE Partner

Founder of Women Pharmacist Day

Founder of Women Pharmacist Day
pharmacist moms group logo
Stay In Touch
an mjh life sciences brand

© 2021 MJH Life Sciences and Pharmacy Times®. All rights reserved.

Privacy Policy